Latest News
Oruka Therapeutics, Inc.
- Oruka Therapeutics general counsel sells $706k in shares
- Form 4 Oruka Therapeutics Inc: Paul T. Quinlan (General Counsel) For: 20 October
- Oruka Therapeutics leads with ORKA-001, a promi...
- Oruka Therapeutics: The Psoriasis Market Becoming A Barbell, And ORKA-001 Owns The Far End
- Form 144 ORUKA THERAPEUTICS INC For: 17 October By Investing.com
- Oruka Therapeutics CMO Joana Goncalves sells $523,647 in stock
- Oruka Therapeutics senior vice president Arjun Agarwal sells $805,888 in stock
- Form 4 Oruka Therapeutics Inc: Arjun Agarwal (Senior Vice President, Finance) For: 12 October
- Piper Sandler reiterates Oruka Therapeutics stock rating on pipeline catalysts
- Oruka Therapeutics (ORKA) Just Gave Investors A Fresh Question
- Oruka Therapeutics CEO Klein sells $2.09m in stock
- How Investors Are Reacting To Oruka Therapeutics (ORKA) Positive Psoriasis Trial Results
Headlines from the last 30 days, linking to the original publishers. See all market news →